Accuracy of monitoring serum carcinoembryonic antigen levels in postoperative stage III colorectal cancer patients is limited to only the first postoperative year

Surgery Today

Volumn 41, Issue 10, 2011, Pages 1357-1362

  Hara, Masayasu ^a   Sato, Mikinori ^a   Takahashi, Hiroki ^a   Takayama, Satoru ^a   Takeyama, Hiromitsu ^a  

^a NAGOYA CITY UNIVERSITY   (Japan)

Author keywords

Carcinoembryonic antigen; Colorectal cancer; Follow up

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER STAGING; CLINICAL EFFECTIVENESS; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE MARKER; FEMALE; FOLLOW UP; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PATIENT MONITORING; POSTOPERATIVE CARE; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIKELIHOOD FUNCTIONS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; NEOPLASM STAGING; RECURRENCE; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 80855124889     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-010-4519-2     Document Type: Article

References (26)

1. Rockall TA, McDonald PJ. Carcinoembryonic antigen: its value in the follow-up of patients with colorectal cancer. Int J Colorectal Dis 1999;13:73-7. (Pubitemid 29295309)
2. Mariani G, Carmellini M, Bonaguidi F, Benelli MA, Toni MG. Serum CEA monitoring in the follow-up of colorectal cancer patients with negative preoperative serum CEA. Eur J Cancer 1980;16:1099-103. (Pubitemid 10043676)
3. Desch CE, Benson AB 3rd, Somerfield MR, Flynn PJ, Krause C, Loprinzi CL, et al. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol 2005;23:8512-9.
4. Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N, Macdonald JS, et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 2006;24:5313-27. (Pubitemid 46631379)
5. Tveit KM. ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of rectal cancer. Ann Oncol 2003;14: 1006-7. (Pubitemid 36950160)
6. Duffy MJ, van Dalen A, Haglund C, Hansson L, Klapdor R, Lamerz R, et al. Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines. Eur J Cancer 2003;39:718-27. (Pubitemid 36315986)
7. Nakayama T, Watanabe M, Teramoto T, Kitajima M. CA19-9 as a predictor of recurrence in patients with colorectal cancer. J Surg Oncol 1997;66:238-43. (Pubitemid 28013697)
8. Reiter W, Stieber P, Reuter C, Nagel D, Lau-Werner U, Lamerz R. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer. Anticancer Res 2000;20: 5195-8. (Pubitemid 32319106)
9. Filella X, Molina R, Pique JM, Garcia-Valdecasas JC, Grau JJ, Novell F, et al. Use of CA 19-9 in the early detection of recurrences in colorectal cancer: comparison with CEA. Tumour Biol 1994;15:1-6. (Pubitemid 24122938)
10. Duffy MJ, van Dalen A, Haglund C, Hansson L, Holinski-Feder E, Klapdor R, et al. Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer 2007;43:1348-60. (Pubitemid 46874070)
11. Duffy MJ. Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clin Chem 2001;47:624-30. (Pubitemid 32275803)
12. Korner H, Soreide K, Stokkeland PJ, Soreide JA. Diagnostic accuracy of serum-carcinoembryonic antigen in recurrent colorectal cancer: a receiver operating characteristic curve analysis. Ann Surg Oncol 2007;14:417-23. (Pubitemid 46175284)
13. Bhandari M, Guyatt GH. How to appraise a diagnostic test. World J Surg 2005;29:561-6. (Pubitemid 41187389)
14. Wichmann MW, Lau-Werner U, Muller C, Hornung HM, Stieber P, Schildberg FW. Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer. Anticancer Res 2000;20:4953-5. (Pubitemid 32319057)
15. Fernandes LC, Kim SB, Saad SS, Matos D. Value of carcinoembryonic antigen and cytokeratins for the detection of recurrent disease following curative resection of colorectal cancer. World J Gastroenterol 2006;12:3891-4. (Pubitemid 44028404)
16. De Salvo L, Razzetta F, Arezzo A, Tassone U, Bogliolo G, Bruzzone D, et al. Surveillance after colorectal cancer surgery. Eur J Surg Oncol 1997;23:522-5. (Pubitemid 28059776)
17. Moertel CG, Schutt AJ, Go VL. Carcinoembryonic antigen test for recurrent colorectal carcinoma. Inadequacy for early detection. JAMA 1978;239:1065-6. (Pubitemid 8290953)
18. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology. J Clin Oncol 1996;14:2843-77.
19. Hara M, Kanemitsu Y, Hirai T, Komori K, Kato T. Negative serum carcinoembryonic antigen has insufficient accuracy for excluding recurrence from patients with Dukes C colorectal cancer: analysis with likelihood ratio and posttest probability in a follow-up study. Dis Colon Rectum 2008;11:1675-80.
20. Sackett DL, Strauss SE, Richardson WS. Evidence-based medicine: how to practice and teach EBM. New York: Churchill Livingstone; 2000.
21. Akobeng AK. Understanding diagnostic tests 2: likelihood ratios, pre- and post-test probabilities and their use in clinical practice. Acta Paediatr 2007;96:487-91. (Pubitemid 46466110)
22. Davidson M. The interpretation of diagnostic test: a primer for physiotherapists. Aust J Physiother 2002;48:227-32. (Pubitemid 35021639)
23. Welch JP, Donaldson GA. Detection and treatment of recurrent cancer of the colon and rectum. Am J Surg 1978;135:505-11. (Pubitemid 8336686)
24. Sadahiro S, Suzuki T, Ishikawa K, Nakamura T, Tanaka Y, Masuda T, et al. Recurrence patterns after curative resection of colorectal cancer in patients followed for a minimum of ten years. Hepatogastroenterology 2003;50:1362-6. (Pubitemid 37186484)
25. Moerte, CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen C. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer JAMA 1993;270:943-7. (Pubitemid 23244732)
26. McCall JL, Black RB, Rich CA, Harvey JR, Baker RA, Watts J, et al. The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer. Dis Colon Rectum 1994;37:875-81. (Pubitemid 24281920)